Ipsen
Corporate VC
Ipsen Ventures is the corporate venture arm of French biopharmaceutical company Ipsen, backing biotech startups in oncology, rare disease, and neuroscience.
2+ investments · 1 portfolio companies
Early Stage
Biotech
- Website
- ipsen.com
- Portfolio Company
- 1
- Total Investments
- 2
- Last Investment
- Oct 2025
- Geographic Focus
- Europe, United States
Investment Thesis
Ipsen Ventures invests alongside other pharma-linked venture arms in biotech aligned with Ipsen's therapeutic focus, including oncology drug discovery, as with its Series A investment in Pyxis Oncology.
Ipsen is a Corporate VC firm. It has made 2 investments in Biotech, including Pyxis Oncology.
Portfolio1
Co-investors6
Sign up to view co-investors
6 co-investors across 6 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×4 · Corporate VC ×2 · 3 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/ipsen"><img src="https://indexed.vc/api/badge/investor/ipsen" alt="Ipsen on Indexed.vc" width="260" height="76" /></a>